Caudill Cortney, SVP and chief operating officer at Halozyme Therapeutics ($HALO), sold about $2.23 million in company shares across four open market transactions over the past year. Her most recent sale occurred on March 10, 2026. These sales rank 3,280th among 11,678 individual insiders, below the average sale amount of $8.59 million and 6.4 transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | M | Common Stock | 20000 | $33.51 | 34,366.0000 | 123,904,000 | 139.22% | 0.02% |
| March 10, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | M | Option to Purchase Common Stock | 1546 | $33.51 | 67,678.0000 | 123,904,000 | 2.23% | 0.00% |
| March 9, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | M | Option to Purchase Common Stock | 20000 | $33.51 | 69,224.0000 | 123,904,000 | 22.42% | 0.02% |
| March 10, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | S | Common Stock | 8857 | $67.64 | 7,055.0000 | 123,904,000 | 55.66% | 0.01% |
| March 10, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | M | Common Stock | 1546 | $33.51 | 15,912.0000 | 123,904,000 | 10.76% | 0.00% |
| March 9, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | S | Common Stock | 2100 | $68.25 | 14,366.0000 | 123,904,000 | 12.75% | 0.00% |
| March 9, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | S | Common Stock | 17900 | $67.75 | 16,466.0000 | 123,904,000 | 52.09% | 0.01% |
| Feb. 20, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | M | Common Stock | 2666 | $0.00 | 15,403.0000 | 123,904,000 | 20.93% | 0.00% |
| Feb. 20, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | F | Common Stock | 1037 | $70.98 | 14,366.0000 | 123,904,000 | 6.73% | 0.00% |
| Feb. 20, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | M | Restricted Stock Units | 2666 | $0.00 | 7,998.0000 | 123,904,000 | 25.00% | 0.00% |
| Feb. 9, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | A | Option to Purchase Common Stock | 14047 | $0.00 | 14,047.0000 | 123,904,000 | 9999.99% | 0.01% |
| Feb. 9, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | A | Performance Stock Units | 14751 | $0.00 | 14,751.0000 | 123,904,000 | 9999.99% | 0.01% |
| Feb. 9, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | A | Performance Stock Units | 2403 | $0.00 | 13,886.0000 | 123,904,000 | 20.93% | 0.00% |
| Feb. 9, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | A | Restricted Stock Units | 13047 | $0.00 | 13,047.0000 | 123,904,000 | 9999.99% | 0.01% |
| Nov. 1, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | M | Common Stock | 9326 | $0.00 | 17,000.0000 | 124,449,000 | 121.53% | 0.01% |
| Nov. 1, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | M | Restricted Stock Units | 9326 | $0.00 | 18,651.0000 | 124,449,000 | 33.33% | 0.01% |
| Nov. 1, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | S | Common Stock | 4263 | $65.19 | 12,737.0000 | 124,449,000 | 25.08% | 0.00% |
| Oct. 3, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | A | Restricted Stock Units | 3625 | $0.00 | 3,625.0000 | 124,449,000 | 9999.99% | 0.00% |
| Oct. 3, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | A | Option to Purchase Common Stock | 9031 | $0.00 | 9,031.0000 | 124,449,000 | 9999.99% | 0.01% |